← Alle Unternehmen
Über das Unternehmen
Today, 500m people with diabetes still life in constant stress, tension and danger despite modern technology. OneTwenty's Machine Learning system has been developed to solve this and give back health and peace of mind to people. The technology is integrated in existing medical devices like insulin pumps or insulin pens and controls insulin dosing based on self-learning, individualized models for each user and with a very short start-up phase. Our B2B business model is to license the solution to market-leading medtech companies and therefore revolutionize their product offering. Win-win-win. Beyond diabetes, this technology can be applied to countless fields of diseases to improve digital therapeutics and medical hardware.